A 61-year-old man with stable angina and a prior NSTEMI underwent percutaneous coronary intervention 3 months ago with a drug-eluting stent. He is on dual antiplatelet therapy with aspirin and ticagrelor. He has diabetes and chronic kidney disease but no major bleeding history. According to CCS antiplatelet guidelines, which statement best reflects his recommended antiplatelet therapy?